Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2024

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Show Description +

Dr. Weng shares the pooled safety analysis of 8 mg aflibercept (Eylea HD, Regeneron) for up to 96 weeks in the CANDELA, PHOTON, and PULSAR trials.

Posted: 8/01/2024

Keywords:

retina-meeting-recap

•

aflibercept

•

Eylea

•

EYLEA HD

•

Regeneron Pharmaceuticals

•

Clinical Trials

Up Next

Exploring DME Outcomes Based on Baseline Vision

Exploring DME Outcomes Based on Baseline Vision

Diana V. Do, MD

The PDS: Technical Changes and Clinical Experiences

The PDS: Technical Changes and Clinical Experiences

Dante J. Pieramici, MD

Pegcetacoplan in the Trials and the Real-World

Pegcetacoplan in the Trials and the Real-World

David A. Eichenbaum, MD

An Update on AVD-104 for the Treatment of GA

An Update on AVD-104 for the Treatment of GA

Rishi P. Singh, MD

Gene Therapy for Wet AMD Shows Promise

Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Using Retinal Imaging to Identify Alzheimer Biomarkers

Using Retinal Imaging to Identify Alzheimer Biomarkers

Sruthi Arepalli, MD

The Effect of Vitrectomy on AMD Progression

The Effect of Vitrectomy on AMD Progression

Chase Ludwig, MD

Using AI to Track GA Treatment Response

Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

More on Faricimab for DME: Efficacy and Safety

More on Faricimab for DME: Efficacy and Safety

Chirag Jhaveri, MD

Back to All Videos

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Dr. Weng shares the pooled safety analysis of 8 mg aflibercept (Eylea HD, Regeneron) for up to 96 weeks in the CANDELA, PHOTON, and PULSAR trials.

Posted: 8/01/2024

Keywords:

retina-meeting-recap

•

aflibercept

•

Eylea

•

EYLEA HD

•

Regeneron Pharmaceuticals

•

Clinical Trials

Please log in to leave a comment.

More From ASRS: 2024 Coverage

Using Retinal Imaging to Identify Alzheimer Biomarkers

Using Retinal Imaging to Identify Alzheimer Biomarkers

Sruthi Arepalli, MD

The Effect of Vitrectomy on AMD Progression

The Effect of Vitrectomy on AMD Progression

Chase Ludwig, MD

Using AI to Track GA Treatment Response

Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

More on Faricimab for DME: Efficacy and Safety

More on Faricimab for DME: Efficacy and Safety

Chirag Jhaveri, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2024.